You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
JavaScript Required
JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Skip to Content
Accessibility Information
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Maryland Department of Health
Maternal and Child Health Bureau (MCHB)
Maternal and Child Health Bureau (MCHB)
Currently selected
Section Menu
Home
A-Z Index
Babies Born Healthy
Child and Adolescent Health
Child Fatality Review
Child Maltreatment
Family and Community Health
Family Planning
Fetal and Infant Mortality Review
Home Visiting Program
Maternal Mortality Review
Pregnancy Care and HIV, Syphilis & Hepatitis Prevention
Pregnancy Risk Assessment Monitoring System (PRAMS)
Maryland Hospital Breastfeeding Policy Recommendations
Maternal and Perinatal Health Program
Title V
Women's Health
Office of Quality Initiatives
Urgent Warning Signs in Pregnancy and Postpartum
Other Links
Medicaid Child Health Programs
Links and Related Resources
MCH Epidemiology
Office of Children and Youth with Specific Health Care Needs
Office of the Maryland WIC Program
Postpartum Referral
What's New?
Where to Find Services
Contact Us
Recent
Currently selected
Left_Content
Main_Content
Privacy Issues/EMRs/HIPAA
EMRs can be used to prompt providers in different health care settings to screen for IPV and to the correct referrals, counseling and services to make sure that women get the help they need.
Given the long-standing health effects of IPV, Health Information Technology is invaluable in coordinating between providers and providing seamless coverage to manage these long-term health effects.
Personal and sensitive health information should be de-identified whenever possible
Individuals should have the right to access, correct, amend, and supplement their own health information.
For IPV victims, the ability to review records may increase trust in a provider and a deeper understanding of how her confidentiality is being protected.
Individuals should receive notice of how health information is used and disclosed, including specific notification of limits of confidentiality.
We underscore the necessity for reminders being sent per patient preference.
It is critical that providers do communicate with patients per the patient preference, as there are real safety and privacy concerns to be considered.
All patients who disclose IPV should be offered preference on how or if follow up communication should take place, and no mention of DV verbally or in writing should be made in the follow up reminders.
Victims should be permitted to provide alternative contact information for different types of communication.
If a woman receives her insurance coverage through her husband’s employer, his address and email may be primary on the account.
She should never be required to have communications go to someone other than who she chooses.
Providers must offer and respect patient’s choice of communication preferences, including by phone, by email, etc., and under what circumstances.
This should be built into the EMR as mandatory fields.
Privacy safeguards and consents should follow the data.
Providers should have broad discretion to withhold information when disclosure could harm the patient.
There should be strong and enforceable penalties for violations of privacy and consents both in a clinical setting and across information exchanges.
For more information:
ALL-INCLUSIVE ONLINE TOOLS FOR PROVIDERS AND ADVOCATES
Center_Content
Right_Content
IPV LINKS
Definitions
Screening
Why, Who, When, How
*Sample Too
l
Clinical Cues/Health Impact of IPV
Responding
When the Answer is
Yes or No
Safety Assessment
Reporting Requirements
Referring
Maryland Domestic
Violence Programs
Hotlines
Documentation
Coding/Billing
Privacy Issues
EMRs, HIPAA
Current MDH Projects
Ordering Materials
Additional Information
Click below to return to our home
page
.
January, 2014
Rt_bottom_Content